BioSpace News Archive

Business

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2020

Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2020 on Tuesday, November 19, 2019.

November 5, 2019
·
1 min read
Business

RedHawk Commences Social Media Campaign Focused On SANDD™ Needle Incineration Units

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”) announced today it has commenced its social media advertising campaign by engaging Singer Marketing, Inc.

November 5, 2019
·
5 min read
Genetown

Medisafe Announces Strong Results from Digital Medication Management Programs

Medisafe, , and Merck KGaA, Darmstadt, Germany, today announced strong results from their customized digital medication management programs for patients with chronic conditions in Brazil, Russia and Mexico

November 5, 2019
·
3 min read
BioForest

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases

Shape Therapeutics, Inc. (ShapeTx), a development-stage biotechnology company leading the field of RNA-editing gene therapy, announces $35.5M in Series A financing, led by New Enterprise Associates (NEA), with additional participation from CureDuchenne Ventures.

November 5, 2019
·
7 min read
Job Trends

Sonic Healthcare USA Signs Exclusive License Agreement with UPMC for Broader Patient Access to the ThyroSeq® Genomic Classifier

Sonic Healthcare USA (Sonic) and UPMC have entered into an exclusive long-term, 15-year license agreement for access to ThyroSeq® Genomic Classifier.

November 5, 2019
·
4 min read
Job Trends

ChemoBrain Co.™ Announces Launch of First-Ever Treatment for Cancer Survivors Suffering from the Cognitive Side Effects of Chemotherapy

ChemoBrain Clear™ is the first and only product on the market formulated to treat the cognitive side effects of chemotherapy, commonly referred to as “chemo brain.”

November 5, 2019
·
2 min read
Pharm Country

GIANTmicrobes Boost Awareness of Chronic Disease and Digestive Health

GIANTmicrobes, headquartered in Stamford, CT, has launched three new groups of health products to build awareness for digestive diseases, chronic illnesses and biology education.

November 5, 2019
·
2 min read
BioCapital

Lupus Foundation of America Announces Development of Next Generation Data Platform to Advance Lupus Research

Today, the Lupus Foundation of America is excited to announce the development of a next generation data platform supporting the acceleration and advancement of lupus research

November 5, 2019
·
3 min read
Business

The Alliance for Regenerative Medicine Releases Q3 2019 Sector Report, Highlighting Industry Trends and Metrics

The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly sector report, offering an in-depth look at cell therapy, gene therapy, tissue engineering, and broader global regenerative medicine sector trends and metrics in the third quarter of 2019.

November 5, 2019
·
2 min read
Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics With a $57 Million Series A

Innovative Targeting Solutions (ITS) today announced that, A2 Biotherapeutics, Inc., co-founded in 2018 with Alexander Kamb, former SVP of Research at Amgen Inc., has emerged after operating in stealth mode for the last 18 months.

November 5, 2019
·
2 min read